[SaneVax: The package insert for Gardasil clearly states it has not been tested for carcinogenicity, the potential to cause cancer. Although that fact should be enough to raise an eyebrow or two, there are many other unanswered questions about HPV vaccines. The article below presents many of them quite nicely.]
Gardasil May Cause Cancer
By Sandy Lunoe, VacTruth
When we see the term “cancer vaccine” in connection with the HPV (human papilloma virus) vaccine Gardasil we may naturally assume that it prevents cervical cancer, yet there is no evidence whatsoever that this is the case. (1) On the contrary, the term is incorrect because unbelievable though it may sound Gardasil may actually cause cancer. This fact is being ignored by Merck the manufacturer and other promoters including doctors and health authorities.
NOT TESTED FOR CARCINOGENICITY
Information in the package insert states that the vaccine has not been tested for carcinogenicity. (2) Why has this not been done? Absence of evidence is not evidence of absence! There appears to be no official requirement for vaccines to be tested for carcinogenicity and no incentive for manufacturers to do so. Many experts consider that vaccines are conducive towards the dramatic worldwide increase in cancer cases.
REPLACEMENT MAY CAUSE DEVELOPMENT OF CANCER
A normal phenomenon in virology is that virus strains which have been removed are replaced by new ones. It is not known by anyone, including the vaccine manufacturer whether the new virus strains are more carcinogenic than the original ones which have been removed.
The chief editor of the Journal of the Norwegian Medical Association, immunologist Charlotte Haug writes about several unanswered questions including that of replacement in her article “We Need to Talk about HPV Vaccination – Seriously”:
Abhorred vacuum. There is another serious question that may be answered sooner: what effect will the vaccine have on the other cancer-causing strains of HPV? Nature never leaves a void, so if HPV-16 and HPV-18 are suppressed by an effective vaccine, other strains of the virus will take their place. The question is, will these strains cause cervical cancer?
Results from clinical trials are not encouraging. Vaccinated women show an increased number of precancerous lesions caused by strains of HPV other than HPV-16 and HPV-18. The results are not statistically significant, but if the trend is real – and further clinical trials should tell us in a few years – there is reason for serious concern. (3)